Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Aristimuño

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Neuroimmunology|May 16, 2006
Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapyJoaquín Navarro, Carol Aristimuño, Silvia Sánchez-Ramón, et al.
Journal of Neuroimmunology|October 7, 2008
Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapseCarol Aristimuño, Joaquín Navarro, Clara de Andrés, et al.
International Journal of Molecular Sciences|July 28, 2012
Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differencesMarta Tejera-Alhambra, Bárbara Alonso, Roseta Teijeiro, et al.
Immunology Letters|December 9, 2004
Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activitySilvia Sánchez-Ramón, Joaquín Navarro A, Carol Aristimuño, et al.
Nanomaterials (Basel, Switzerland)|July 2, 2021
A Complete In Vitro Toxicological Assessment of the Biological Effects of Cerium Oxide Nanoparticles: From Acute Toxicity to Multi-Dose Subchronic Cytotoxicity StudyAdrián García-Salvador, Alberto Katsumiti, Elena Rojas, et al.
Journal of Neuroimmunology|May 19, 2009
Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal studyClara de Andrés, Carol Aristimuño, Manuel Bartolomé, et al.
Clinical Immunology (Orlando, Fla.)|November 11, 2009
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year studyCarol Aristimuño, Clara de Andrés, Manuel Bartolomé, et al.
European Journal of Clinical Investigation|December 1, 2010
Estradiol-dependent perforin expression by human regulatory T-cellsLarissa Valor, Roseta Teijeiro, Carol Aristimuño, et al.
Clinical and Experimental Medicine|January 10, 2012
Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosisCarol Aristimuño, Roseta Teijeiro, Lara Valor, et al.
Journal of Neuroimmunology|December 13, 2006
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosisClara de Andrés, Carol Aristimuño, Virginia de Las Heras, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Neuroimmunology|May 16, 2006
Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapyJoaquín Navarro, Carol Aristimuño, Silvia Sánchez-Ramón, et al.
Journal of Neuroimmunology|October 7, 2008
Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapseCarol Aristimuño, Joaquín Navarro, Clara de Andrés, et al.
International Journal of Molecular Sciences|July 28, 2012
Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differencesMarta Tejera-Alhambra, Bárbara Alonso, Roseta Teijeiro, et al.
Immunology Letters|December 9, 2004
Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activitySilvia Sánchez-Ramón, Joaquín Navarro A, Carol Aristimuño, et al.
Nanomaterials (Basel, Switzerland)|July 2, 2021
A Complete In Vitro Toxicological Assessment of the Biological Effects of Cerium Oxide Nanoparticles: From Acute Toxicity to Multi-Dose Subchronic Cytotoxicity StudyAdrián García-Salvador, Alberto Katsumiti, Elena Rojas, et al.
Journal of Neuroimmunology|May 19, 2009
Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal studyClara de Andrés, Carol Aristimuño, Manuel Bartolomé, et al.
Clinical Immunology (Orlando, Fla.)|November 11, 2009
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year studyCarol Aristimuño, Clara de Andrés, Manuel Bartolomé, et al.
European Journal of Clinical Investigation|December 1, 2010
Estradiol-dependent perforin expression by human regulatory T-cellsLarissa Valor, Roseta Teijeiro, Carol Aristimuño, et al.
Clinical and Experimental Medicine|January 10, 2012
Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosisCarol Aristimuño, Roseta Teijeiro, Lara Valor, et al.
Journal of Neuroimmunology|December 13, 2006
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosisClara de Andrés, Carol Aristimuño, Virginia de Las Heras, et al.
Pageof 1